About this trial
This study aims to investigate how visual impairment affects neurophysiological and biomechanical responses during real-world navigation and daily activities, with a focus on the rehabilitative feasibility and impact of assistive technologies. These technologies include applications and wearable devices designed to support various aspects of daily living for individuals with visual impairment. The VIS4ION platform (Visually Impaired Smart Service System for Spatial Intelligence \& On-board Navigation), a wearable system providing tactile and auditory feedback, is one component of this broader study. VIS4ION is designed to enhance environmental awareness and reduce cognitive load during mobility tasks for the visually impaired.
Eligibility criteria
Qualifiers
Age between 18 and 80 years.
Diagnosis of visual impairment (any level, any etiology).
Current use of a primary mobility assistive device (e.g., white cane or guide dog).
Ability to travel independently (without assistance from another person).
Disqualifiers
Significant cognitive dysfunction (score <24 on Folsteins' Mini Mental Status Examination)
Previous neurological illness, complicated medical condition (inclusive of comorbid cognitive impairment)
Significant mobility restrictions; people using walkers and wheelchairs
Pregnancy
Trial design
Treatments tested in this trial
- VIS4ION Platform
Treatment groups
Sponsors and collaborators
NYU Langone Health
Lead sponsor
National Eye Institute (NEI)
Collaborator